CochLear Net Change in Intangible Assets 2023-2024 | CHEOY

CochLear annual/quarterly net change in intangible assets history and growth rate from 2023 to 2024. Net change in intangible assets can be defined as the overall change from the sale and purchase of intangible assets including patents, rights and capitalized software.
  • CochLear net change in intangible assets for the quarter ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • CochLear net change in intangible assets for the twelve months ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • CochLear annual net change in intangible assets for 2024 was $-0.008B, a 50.88% decline from 2023.
  • CochLear annual net change in intangible assets for 2023 was $-0.016B, a 33.6% decline from 2022.
  • CochLear annual net change in intangible assets for 2022 was $-0.024B, a 0% decline from 2021.
CochLear Annual Net Change in Intangible Assets
(Millions of US $)
2024 $-8
2023 $-16
2022 $-24
2021 $N/A
2020 $N/A
2019 $N/A
2018 $N/A
2017 $N/A
2016 $N/A
Sector Industry Market Cap Revenue
Medical Medical Services $12.699B $1.525B
Cochlear Limited provides implantable hearing solutions principally in the Americas, Europe, the Middle East, Africa and the Asia Pacific. The company offers cochlear implants, including Nucleus 7 and Kanso sound processors; Carina middle-ear implants and accessories and Baha bone conduction implants. Cochlear Limited is based in Sydney, Australia.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $146.003B 27.08
CVS Health (CVS) United States $90.597B 11.27
Elevance Health (ELV) United States $69.715B 9.38
Cencora (COR) United States $58.790B 19.58
DiDi Global (DIDIY) China $29.369B 31.20
Labcorp Holdings (LH) United States $22.982B 18.27
Natera (NTRA) United States $22.227B 0.00
BioMerieux (BMXMF) France $17.547B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $15.490B 0.00
ICON (ICLR) Ireland $14.189B 13.65
Medpace Holdings (MEDP) United States $12.736B 33.71
Solventum (SOLV) United States $12.484B 12.88
Viatris (VTRS) United States $12.463B 4.44
Caris Life Sciences,�Inc (CAI) United States $10.720B 0.00
Revvity (RVTY) United States $10.408B 18.34
Avantor (AVTR) United States $8.563B 12.56
Sonic Healthcare (SKHHY) Australia $7.992B 0.00
HealthEquity (HQY) United States $7.874B 34.49
Charles River Laboratories (CRL) United States $7.606B 14.43
Bausch + Lomb (BLCO) Canada $5.133B 34.52
Sotera Health (SHC) United States $4.525B 25.29
BrightSpring Health Services (BTSG) United States $4.244B 32.38
KindlyMD (NAKA) United States $3.998B 0.00
Amplifon S.p.A (AMFPF) Italy $3.937B 21.83
GeneDx Holdings (WGS) United States $3.468B 79.42
Alignment Healthcare (ALHC) United States $3.129B 0.00
Concentras Parent (CON) United States $2.949B 18.71
Surgery Partners (SGRY) United States $2.931B 36.87
Organon (OGN) United States $2.412B 2.63
Premier (PINC) United States $2.106B 19.53
Progyny (PGNY) United States $1.989B 42.06
Ardent Health (ARDT) United States $1.826B 7.05
PACS (PACS) United States $1.788B 0.00
GoodRx Holdings (GDRX) United States $1.560B 26.41
Pediatrix Medical (MD) United States $1.406B 9.39
Teladoc Health (TDOC) United States $1.270B 0.00
Omada Health (OMDA) $1.236B 0.00
Establishment Labs Holdings (ESTA) $1.159B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.962B 0.00
Embecta (EMBC) United States $0.809B 4.74
AMN Healthcare Services Inc (AMN) United States $0.753B 9.31
CareDx (CDNA) United States $0.666B 12.27
QDM (QDMI) Hong Kong, SAR China $0.641B 110.00
Performant Healthcare (PHLT) United States $0.602B 0.00
Nutex Health (NUTX) United States $0.534B 8.09
Agilon Health (AGL) United States $0.510B 0.00
Sonida Senior Living (SNDA) United States $0.484B 0.00
InnovAge Holding (INNV) United States $0.466B 0.00
Auna S.A (AUNA) Luxembourg $0.465B 6.98
SBC Medicals (SBC) United States $0.438B 9.61
COMPASS Pathways (CMPS) United Kingdom $0.414B 0.00
Enhabit (EHAB) United States $0.405B 26.63
So-Young (SY) China $0.395B 0.00
Oncology Institute (TOI) United States $0.329B 0.00
LifeMD (LFMD) United States $0.298B 0.00
Beauty Health (SKIN) United States $0.263B 0.00
Shoulder Innovations (SI) United States $0.186B 0.00
DocGo (DCGO) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.135B 0.00
Sera Prognostics (SERA) United States $0.090B 0.00
Biodesix (BDSX) United States $0.062B 0.00
NeueHealth (NEUE) United States $0.059B 0.00
IceCure Medical (ICCM) Israel $0.051B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.038B 0.00
Basel Medical Group (BMGL) Singapore $0.035B 0.00
SeaStar Medical Holding (ICU) United States $0.022B 0.00
Intelligent Bio Solutions (INBS) United States $0.013B 0.00
Co-Diagnostics (CODX) United States $0.012B 0.00
BioNexus Gene Lab (BGLC) $0.010B 0.00
OSR Holdings (OSRH) United States $0.010B 0.00
ModivCare (MODV) United States $0.008B 0.00
XWELL (XWEL) United States $0.006B 0.00
INVO Fertility (IVF) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
Aclarion (ACON) United States $0.004B 0.00
Pheton Holdings (PTHL) China $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00